Filing Flows › Ecovyst (ECVT) › Q3 2026
Ecovyst (ECVT) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Ecovyst (ECVT) reported revenue of $309M for the third quarter 2026 (Q3 2026), +51% from a year earlier and +23% from the quarter before. Operating margin was 9.5%, net earnings $18.2M (5.9% of revenue).
Ecovyst, Q3 2026: revenue $309M (+51% year over year), operating margin 9.5%, net earnings $18.2M, operating cash flow $25.2M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $309M | +23% | +51% |
| Gross profit | $58.7M | +18% | +13% |
| Operating profit | $29.2M | +51% | +3% |
| Net earnings | $18.2M | +131% | — |
| Operating cash flow | $25.2M | -27% | -54% |
What changed
Revenue was $308.6M in Q3 2026, up 51% year over year and up 23% from the previous quarter. Virgin sulfuric acid was the largest line at 53% of revenue. Virgin sulfuric acid added $66.5M year over year (up 69%), 64% of the total change.
Gross margin was 19.0%, down 6.4 points from Q3 2025. Operating profit was $29.2M, a 9.5% margin (down 4.3 points year over year). Of the extra revenue versus Q3 2025, 1% reached operating profit, below the 14% margin then. Operating expenses grew 24% against revenue growth of 51%. The fastest-growing cost line was SG&A (+30%). Net earnings were $18.2M. The effective tax rate was 20.0%.
Operating cash flow was $25.2M (down 54% year over year), 139% of net earnings. Non-cash charges added back $22.8M of depreciation and amortization and $2.4M of share-based compensation. Working capital and other items used $18.1M. Capital expenditures of $27.9M exceeded it, leaving free cash flow of −$2.6M.
Questions
What was Ecovyst's revenue in the third quarter 2026?
Ecovyst (ECVT) reported revenue of $309M for the third quarter 2026 (Q3 2026), +51% from a year earlier and +23% from the quarter before.
Was Ecovyst profitable in the third quarter 2026?
Operating profit was $29.2M (9.5% of revenue) and net earnings $18.2M.
Source: Ecovyst 10-Q on SEC EDGAR.